Chris Kosmidis
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 1%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antifungal resistance and susceptibility 43
- Antimicrobial Resistance in Staphylococcus 7
- Epidemiology 32
- Fungal Infections and Studies 22
- Co-authors
- David W. Denning (31 shared papers)Susan M. Seo (3 shared papers)Glenn W. Kaatz (3 shared papers)George L. Daikos (10 shared papers)Panayotis T. Tassios (6 shared papers)Diixa Patel (2 shared papers)Chris Harris (10 shared papers)G. Petrikkos (7 shared papers)
- Journals
- Journal of Fungi (6 papers)Medical Mycology (6 papers)Journal of Antimicrobial Chemotherapy (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)Journal of Chemotherapy (4 papers)
- Partner nations
- United KingdomGreeceUnited States
In The Last Decade
Chris Kosmidis
76 papers receiving 2.4k citations
Chris Kosmidis's Hit Papers
Peers
Comparison fields: 5 of 105
- Molecular Medicine 481
- Infectious Diseases 1.2k
- Applied Microbiology and Biotechnology 87
- Endocrinology 152
- Epidemiology 899
Countries citing papers authored by Chris Kosmidis
This map shows the geographic impact of Chris Kosmidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Kosmidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Kosmidis more than expected).
Fields of papers citing papers by Chris Kosmidis
This network shows the impact of papers produced by Chris Kosmidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Kosmidis. The network helps show where Chris Kosmidis may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Kosmidis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The clinical spectrum of pulmonary aspergillosis Hit paper breakdown → | 2014 | 608 |
| 2 | 2009 | 179 | |
| 3 | 2007 | 97 | |
| 4 | 2010 | 90 | |
| 5 | 2018 | 84 | |
| 6 | 2012 | 84 | |
| 7 | 2018 | 73 | |
| 8 | 2008 | 72 | |
| 9 | 2018 | 53 | |
| 10 | 2017 | 47 | |
| 11 | 2020 | 46 | |
| 12 | 2007 | 44 | |
| 13 | 2017 | 44 | |
| 14 | 2011 | 39 | |
| 15 | 2010 | 38 | |
| 16 | 2005 | 36 | |
| 17 | 2020 | 34 | |
| 18 | 2015 | 32 | |
| 19 | 2010 | 31 | |
| 20 | 2020 | 31 |
About Chris Kosmidis
Chris Kosmidis is a scholar working on Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine, Molecular Medicine and Small Animals, having authored 81 papers that have together received 2.5k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (43 papers), Fungal Infections and Studies (22 papers), Antibiotic Resistance in Bacteria (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Infectious Diseases and Mycology (7 papers), Bone health and osteoporosis research (5 papers) and Bacterial Identification and Susceptibility Testing (5 papers). The work is most often cited by research in Molecular Medicine (481 citations), Infectious Diseases (1.2k citations), Applied Microbiology and Biotechnology (87 citations), Endocrinology (152 citations) and Epidemiology (899 citations). Chris Kosmidis has collaborated with scholars based in United Kingdom, Greece and United States. Frequent co-authors include David W. Denning, Susan M. Seo, Glenn W. Kaatz, George L. Daikos, Panayotis T. Tassios, Diixa Patel, Chris Harris, G. Petrikkos, L. S. Tzouvelekis and Felix Bongomin. Their work appears in journals such as Journal of Fungi, Medical Mycology, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy and Journal of Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.